Chemoreduction of orbital recurrence of uveal melanoma by intra-arterial melphalan Journal Article


Authors: Francis, J. H.; Barker, C. A.; Yin, V. T.; Carvajal, R. D.; Chapman, P.; Abramson, D. H.; Gobin, Y. P.
Article Title: Chemoreduction of orbital recurrence of uveal melanoma by intra-arterial melphalan
Abstract: Background/Aims: The treatment of orbital melanoma poses a management challenge. This case explores the delivery of high-dose melphalan to an orbital recurrence of uveal melanoma via intra-arterial delivery of melphalan to the orbit. A 62-year-old man developed recurrent orbital disease 7 months after enucleation for a large uveal melanoma. He received 6 monthly intra-arterial infusions of melphalan to the orbit, ranging in dose from 20 to 30 mg per infusion. Following the last infusion, mild temporary erythema was noted on the forehead along the distribution of the supratrochlear artery. The orbital recurrence was reduced in size by 66% in the longest dimension as measured by magnetic resonance imaging (MRI). However, 9 months following intra-arterial melphalan, tumor regrowth was detected on MRI, and additional treatment options were pursued. Conclusion: This case demonstrates that intra-arterial melphalan can result in nonsustained tumor regression of recurrent orbital uveal melanoma. It suggests that local delivery of high-dose melphalan may be helpful as a neoadjuvant treatment for uveal melanoma, and future studies will be useful to confirm the value of this approach in additional cases of recurrent and possibly in primary uveal melanoma. © 2018 S. Karger AG, Basel.
Keywords: orbit; uveal melanoma; neoplasia; intra-arterial chemotherapy; orbital tumor
Journal Title: Ocular Oncology and Pathology
Volume: 5
Issue: 3
ISSN: 2296-4681
Publisher: Karger  
Date Published: 2019-04-01
Start Page: 186
End Page: 189
Language: English
DOI: 10.1159/000490061
PROVIDER: scopus
PMCID: PMC6489044
PUBMED: 31049326
DOI/URL:
Notes: Article -- Export Date: 3 June 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jasmine Helen Francis
    256 Francis
  2. David H Abramson
    389 Abramson
  3. Paul Chapman
    326 Chapman
  4. Christopher Barker
    218 Barker
  5. Vivian Tsui-Wen Yin
    4 Yin